310
Participants
Start Date
November 1, 2024
Primary Completion Date
November 9, 2026
Study Completion Date
November 9, 2027
LEAF-4L6715
LEAF-4L6715: Administration at a dose of 200mg , for up to 10 days every 12 hours for the first 2 days, followed by once-a-day dosing for the next 8 days (days 3 through 10).
Supportive Care
Supportive care, as considered necessary by the treating physician/Principal Investigator (PI), including mechanical ventilation, in line with therapeutic guidelines for ARDS and Multiorgan Failure
Sorbonne University, Paris
European Cardiovascular Research Center
NETWORK
LEAF4Life, Inc.
INDUSTRY